Literature DB >> 8702915

Insulin signaling in mice expressing reduced levels of Syp.

J M Arrandale1, A Gore-Willse, S Rocks, J M Ren, J Zhu, A Davis, J N Livingston, D U Rabin.   

Abstract

Syp is a protein tyrosine phosphatase implicated in insulin and growth factor signaling. To evaluate the role of syp in insulin's regulation of plasma glucose, we generated knockout mice. Homozygous knockout mice die prior to day 10.5 of embryonic development. Hemizygous mice express half the levels of syp protein compared with their wild type littermates but do not display any gross morphological changes. Total body weight (age 2-10 weeks) and plasma insulin and glucose levels both in fasting and glucose-challenged states were comparable in the wild type and the hemizygous mice. No differences were observed in insulin-induced glucose uptake in soleus muscle and epididymal fat; insulin inhibition of lipolysis was also similar. We injected insulin into the portal vein of the mice to examine upstream events of the insulin signaling cascade. Tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 (IRS-1) from hemizygous tissue was similar to that of wild type tissue. Association of the p85 subunit of phosphatidylinositol 3-kinase to IRS-1 increased an average of 2-fold in both groups. We did not observe an increase of IRS-1/syp association after insulin administration, but we did note a significant basal association in both wild type and hemizygous tissue. Our results do not support a major role for syp in the acute in vivo metabolic actions of insulin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702915     DOI: 10.1074/jbc.271.35.21353

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.

Authors:  T M Saxton; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  SHP-2 tyrosine phosphatase in human diseases.

Authors:  Hong Zheng; Shawn Alter; Cheng-Kui Qu
Journal:  Int J Clin Exp Med       Date:  2009-01-30

Review 3.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

4.  Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction.

Authors:  A M O'Reilly; B G Neel
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.

Authors:  C K Qu; Z Q Shi; R Shen; F Y Tsai; S H Orkin; G S Feng
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 6.  The IRS-signalling system: a network of docking proteins that mediate insulin action.

Authors:  M F White
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.

Authors:  T M Saxton; M Henkemeyer; S Gasca; R Shen; D J Rossi; F Shalaby; G S Feng; T Pawson
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

8.  Hepatic Src homology phosphatase 2 regulates energy balance in mice.

Authors:  Naoto Nagata; Kosuke Matsuo; Ahmed Bettaieb; Jesse Bakke; Izumi Matsuo; James Graham; Yannan Xi; Siming Liu; Alexey Tomilov; Natalia Tomilova; Susan Gray; Dae Young Jung; Jon J Ramsey; Jason K Kim; Gino Cortopassi; Peter J Havel; Fawaz G Haj
Journal:  Endocrinology       Date:  2012-05-22       Impact factor: 4.736

9.  Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.

Authors:  C Li; J M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

10.  Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis.

Authors:  Ahmed Bettaieb; Kosuke Matsuo; Izumi Matsuo; Naoto Nagata; Samah Chahed; Siming Liu; Fawaz G Haj
Journal:  Metabolism       Date:  2011-02-25       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.